Siemens Healthineers : Q4 due 8 November – Adjusting estimates ahead of results
>Q4 due 8 November – Solid quarter expected - Siemens Healthineers’ Q4 revenues of € 5,932m (-1.1% y-o-y, 1% vs consensus) should be driven by comparable sales growth of 4.3%, but should be hold back by forex headwind of 540bp. Imaging should show 7.9% comparable sales growth impacted by slight headwind from China. We forecast Diagnostics to be down by 13% on a comparable base, but to show some sequential improvement compared to Q3 (-20% y-o-y). On the other hand, Var...Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company is developing its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value. Siemens AG is a majority shareholder of the Company. The Company is active worldwide.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.